Search
for
Sort by
Research 331–360 of 1000+
- Pmg-1 and Pmg-2 constitute a novel family of KAP genes differentially expressed during skin and mammary gland development
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- Re-epithelialization of the skin following CO 2 laser resurfacing
- The role of ketoconazole 2% shampoo in the treatment and prophylactic management of dandruff
- Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors
- Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis
- Expression patterns of the glial cell line–derived neurotrophic factor, neurturin, their cognate receptors GFRα-1, GFRα-2, and a common signal transduction element c-Ret in the human skin hair follicles
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- The Bio-Safety Concerns of Three Domestic Temporary Hair Dye Molecules: Fuchsin Basic, Victoria Blue B and Basic Red 2
- Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
- Minoxidil induced hypertrichosis in a 2 year-old child
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Timely Wound Healing Is Dependent on Endothelial but Not on Hair Follicle Stem Cell Toll-Like Receptor 2 Signaling
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss
- A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Alopecia areata: Part 2: treatment.
- (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Genetic association of complement component 2 polymorphism with systemic lupus erythematosus
- Activation of mitochondrial aldehyde dehydrogenase 2 promotes hair growth in human hair follicles
- Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production
- Docking and Molecular Dynamics Identify Leads against 5 Alpha Reductase 2 for Benign Prostate Hyperplasia Treatment
- Neurological post‐acute sequelae of SARS‐CoV‐2 infection
- Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study
- trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes
- Diagnosis of Trichothiodystrophy in 2 Siblings
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2